Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 515

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy

Open access
Chen, Yunching, Zhu, Xiaodong, Zhang, Xiaoju, Liu, Bin, Huang, Leaf · 2010 · Molecular Therapy

Abstract

Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have developed a LPH (liposome-polycation-hyaluronic acid) nanoparticle formulation modified with tumor-targeting single-chain antibody fragment (scFv) for systemic delivery of small interfering RNA (siRNA) and microRNA (miRNA) into experimental lung metastasis of murine B16F10 melanoma. The siRNAs delivered by the scFv targeted nanoparticles efficiently downregulated the target genes (c-Myc/MDM2/VEGF) in the lung metastasis. Two daily intravenous injections of the combined siRNAs in the GC4-targeted nanoparticles significantly reduced the tumor load in the lung. miRNA-34a (miR-34a) induced apoptosis, inhibited survivin expression, and downregulated MAPK pathway in B16F10 cells. miR-34a delivered by the GC4-targeted nanoparticles significantly downregulated the survivin expression in the metastatic tumor and reduced tumor load in the lung. When miR-34a and siRNAs were co-formulated in GC4-targeted nanoparticles, an enhanced anticancer effect was observed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2010.136

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 6

  1. Zhu, 2009, Identification of internalizing human single chain antibodies targeting brain tumor sphere cells, Mol Cancer Ther
  2. Xia, 2006, Construction of human ScFv phage display library against ovarian tumor, J Huazhong Univ Sci Technol Med Sci, 26, 497, 10.1007/s11596-006-0502-y · doi:10.1007/s11596-006-0502-y
  3. Tsantili, 1999, High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor, J Neuroimmunol, 94, 15, 10.1016/S0165-5728(98)00195-7 · doi:10.1016/s0165-5728(98)00195-7
  4. Chen, 2009, Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure, Med Oncol, 26, 491, 10.1007/s12032-008-9161-0 · doi:10.1007/s12032-008-9161-0
  5. Ruvkun, 2006, Clarifications on miRNA and cancer, Science, 311, 36, 10.1126/science.311.5757.36d · doi:10.1126/science.311.5757.36d
  6. Conrad, 2009, Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion, J Mol Med, 87, 507, 10.1007/s00109-009-0446-3 · doi:10.1007/s00109-009-0446-3

Cited by

Metadata

Authors
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2010-09
Volume
18
Issue
9
Pages
1650-1656
ISSN
1525-0016 (ISSN-L)
OpenAlex
W1972461780
Cited by
515
References
22
FWCI
16.90
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.